2022 So far In Venture Capital
Precision and personalized medicine: deals decreased significantly in clinical trials in H2 2021
Deals relating to precision and personalized medicine have seen a decrease of 54.1% from H2 2020 to H2 2021.
Digitisation: deals drop significantly in clinical trial operations in H2 2021
Revealed: countries with most M&A deals in the pharma industry
Healthtech related deals in the clinical trial operations industry decreased in H1 2021
AI-related deals in the clinical trial operations industry decreased in H1 2021
Indian pharma deals landscape shaped by Covid-19
